StockData
Nuo Therapeutics, Inc. logo

Nuo Therapeutics, Inc. (AURX) bonds

AURXOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 8/30
$1.26−0.04 (-3.08%)

Close on Oct 19, 2026Market cap $60.99MP/E –Yield –

Debt

Borrowings on the balance sheet, Jun 30, 2026

Nuo Therapeutics reports no long-term debt line

Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.

Notes and loans outstanding

As tagged in Nuo Therapeutics's 10-Q for the period ended May 31, 2026

IssueCouponAmount issued
Initial Notes10.00%–
Interim Notes12.00%–
Loan Agreement With Four Lenders10.00%$500.00K
Loan Agreement With The Initial Lenders–$675.00K
The2019 Senior Secured Notes12.00%$305.00K

Companies tag their debt differently: some list every note, others group notes by issuance year or by type, so the list may not add up to total debt. Notes that matured before today are hidden. Source: 10-Q.

Credit facilities

Revolving credit lines and other committed borrowing capacity

FacilitySize
The2018 Convertible Notes$205.00K

See a number that looks wrong?